UCB Pharma GmbH
Schwarz Pharma AG: Release pursuant to Section 26 para. 1 sentence 1 of the German Securities Trading Act (WpHG)
SCHWARZ PHARMA AG / Voting Rights Announcements Release of a Voting Rights announcement, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------- Angaben zum Emittenten: Name: Schwarz Pharma AG Adresse: Alfred-Nobel-Str. 10, 40789 Monheim am Rhein Staat: Deutschland Inhalt der Stimmrechtsmitteilung: On October 11, 2007, Schwarz Pharma AG has received the following voting rights announcements under section 21 para. 1 of the German Securities Trading Act (Stimmrechtsmitteilungen): 1. Voting Rights Announcement of Paul E. Singer, U.S.A.: 'I, the undersigned Paul E. Singer, hereby inform you pursuant to Sec. 21 para. 1 WpHG that my share in the voting rights of SCHWARZ PHARMA (ISIN DE0007221905) exceeded the threshold of 5% on October 5, 2007 and amounts,as of such date, to 5.03% (this corresponds to 2,477,732 out of a total of 49,261,006 voting rights). Thereof, (i) 0.002% of the SCHWARZ PHARMA AG voting rights (corresponding to 1,000 voting rights) are to be attributed to me pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG, and (ii) 5.03% of the SCHWARZ PHARMA AG voting rights (corresponding to 2,476,732 voting rights) belong to Merrill Lynch International, London, U.K. and are to be attributed to me pursuant to Sec. 22 para. 1 sentence 1 No. 2 in conjunction with sentence 2 WpHG. Of the last mentioned 5.03% of the SCHWARZ PHARMA AG voting rights (corresponding to 2,476,732 voting rights), 3.03% of the SCHWARZ PHARMA AG voting rights (corresponding to 1,492,552 voting rights) are also to be attributed to me from Merrill Lynch International, London, U.K. pursuant to Sec. 22 para. 1 sentence 1 No. 6 in conjunction with sentence 2 WpHG.' 2. Voting Rights Announcement of Braxton Associates, Inc., New York, U.S.A.: 'The undersigned Braxton Associates, Inc. hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of SCHWARZ PHARMA AG (ISIN DE0007221905) exceeded the threshold of 5% on October 5, 2007 and amounts, as of such date, to 5.03% (this corresponds to 2,477,732 out of a total of 49,261,006 voting rights). Thereof, (i) 0.002% of the SCHWARZ PHARMA AG voting rights (corresponding to 1,000 voting rights) are to be attributed to Braxton Associates, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG, and (ii) 5.03% of the SCHWARZ PHARMA AG voting rights (corresponding to 2,476,732 voting rights) belong to Merrill Lynch International, London, U.K. and are to be attributed to Braxton Associates, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 2 in conjunction with sentence 2 WpHG.' 3. Voting Rights Announcement of Elliott Asset Management LLC, New York, U.S.A.: 'The undersigned Elliott Asset Management LLC hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of SCHWARZ PHARMA AG (ISIN DE0007221905) exceeded the threshold of 5% on October 5, 2007 and amounts, as of such date, to 5.03% (this corresponds to 2,477,732 out of a total of 49,261,006 voting rights). Thereof, (i) 0.002% of the SCHWARZ PHARMA AG voting rights (corresponding to 1,000 voting rights) are to be attributed to Elliott Asset Management LLC pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG, and (ii) 5.03% of the SCHWARZ PHARMA AG voting rights (corresponding to 2,476,732 voting rights) belong to Merrill Lynch International, London, U.K. and are to be attributed to Elliott Asset Management LLC pursuant to Sec. 22 para. 1 sentence 1 No. 2 in conjunction with sentence 2 WpHG.' 4. Voting Rights Announcement of Elliott Capital Advisors, L.P., New York, U.S.A.: 'The undersigned Elliott Capital Advisors, L.P. hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of SCHWARZ PHARMA AG (ISIN DE0007221905) exceeded the threshold of 5% on October 5, 2007 and amounts, as of such date, to 5.03% (this corresponds to 2,477,732 out of a total of 49,261,006 voting rights). Thereof, (i) 0.002% of the SCHWARZ PHARMA AG voting rights (corresponding to 1,000 voting rights) are to be attributed to Elliott Capital Advisors, L.P. pursuant to Sec. 22 para. 1 sentence 1 No. 1 WpHG, and (ii) 5.03% of the SCHWARZ PHARMA AG voting rights (corresponding to 2,476,732 voting rights) belong to Merrill Lynch International, London, U.K. and are to be attributed to Elliott Capital Advisors, L.P. pursuant to Sec. 22 para. 1 sentence 1 No. 2 in conjunction with sentence 2 WpHG.' 5. Voting Rights Announcement of Elliott International Capital Advisors Inc., New York, U.S.A.: 'The undersigned Elliott International Capital Advisors Inc. hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of SCHWARZ PHARMA AG (ISIN DE0007221905) exceeded the threshold of 3% on October 5, 2007 and amounts, as of such date, to 3.03% (this corresponds to 1,492,552 out of a total of 49,261,006 voting rights). All of these voting rights belong to Merrill Lynch International, London, U.K., and are to be attributed to Elliott International Capital Advisors Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 6 WpHG.' 6. Voting Rights Announcement of Hambledon, Inc., Cayman Islands, British West Indies: 'The undersigned Hambledon, Inc. hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of SCHWARZ PHARMA AG (ISIN DE0007221905) exceeded the threshold of 3% on October 5, 2007 and amounts, as of such date, to 3.03% (this corresponds to 1,492,552 out of a total of 49,261,006 voting rights). All of these voting rights belong to Merrill Lynch International, London, U.K., and are to be attributed to Hambledon, Inc. pursuant to Sec. 22 para. 1 sentence 1 No. 2 in conjunction with sentence 2 WpHG.' 7. Voting Rights Announcement of Elliott International L.P., Cayman Islands, British West Indies: 'The undersigned Elliott International L.P. hereby informs you pursuant to Sec. 21 para. 1 WpHG that its share in the voting rights of SCHWARZ PHARMA AG (ISIN DE0007221905) exceeded the threshold of 3% on October 5, 2007 and amounts, as of such date, to 3.03% (this corresponds to 1,492,552 out of a total of 49,261,006 voting rights). All of these voting rights belong to Merrill Lynch International, London, U.K., and are to be attributed to Elliott International, L.P. pursuant to Sec. 22 para. 1 sentence 1 No. 2 WpHG.' Schwarz Pharma AG, October 16, 2007 16.10.2007 Financial News transmitted by DGAP ---------------------------------------------------------------------- Language: English Issuer: SCHWARZ PHARMA AG Alfred-Nobel-Str. 10 40789 Monheim Deutschland Internet: www.schwarzpharma.com End of News DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
Upcoming Events
No Events found
Webcasts
No Webcasts found